XRP ETFs Attract $75M in a Week as SOL Funds Hit New 2026 High
The spot exchange-traded funds tracking the performance of Ripple’s cross-border token started the week quietly but built on by the end of it, reaching a new cumulative all-time high.
At the same time, the products tracking Solana’s SOL are on a green-only streak since September 11, and the inflows peaked on Friday with more than $86 million.
XRP ETFs Had a Big Week
The previous business week was a little shaky for the XRP ETFs, as they attracted a more modest $9.56 million, less than half of the $19 million seen in the first few weeks of September. Nevertheless, the financial vehicles still extended their green streak to ten consecutive weeks.
After marking more net outflows last Thursday and Friday, investors stood on the sidelines on September 21 as the new week began, with SoSoData showing no reportable inflows on Monday. However, the trend changed on Tuesday and remained on a high note until Friday.
Investors poured in $20.02 million on September 22, followed by $18.04 million on September 23, another $14.89 million on Thursday, and $22.65 million on Friday. This meant that the five-day trading period ended well in the green, with net inflows of $75.89 million – the best weekly performance in a month.
The cumulative net inflows skyrocketed to another all-time high of $1.79 billion. Bitwise’s XRP fund remains the undisputed leader with cumulative net inflows of $677 million, followed by Franklin’s XRPZ at $501 million and Canary Capital’s XRPC at $489.37 million.
SOL ETFs Had an Even Bigger Week
While the performance of the funds tracking XRP was quite impressive, the SOL counterparts did even better. Monday began with a bang, as the ETFs attracted $26.10 million. Another $28.87 million followed on Tuesday, $13.77 million on Wednesday, and $32.81 million on Thursday, before investors went all in on Friday with a massive inflow day of $86.67 million.
This became the single-best daily inflow since the funds’ inception nearly a year ago. Moreover, the weekly inflows hit a 2026 high with $188.22 million poured in, which was also the second-best ever, only trailing the launch week in October with $199.21 million.
The total net inflows rocketed to a new all-time high of their own at $1.61 billion. Bitwise’s SOL ETF is once again the undisputed leader, with cumulative net inflows of $1.22 billion. Fidelity’s FSOL is far behind at $231.35 million, followed by Grayscale’s GSOL with $164.15 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley Analyst Says SpaceX Stock Price Could Double
Getlink reports 550,000,000 shares outstanding, 642,851,718 total voting rights as of Sept. 30, 2026
Getlink disclosed 550,000,000 ordinary shares outstanding as of Sept. 30, 2026. Theoretical voting rights totaled 642,851,718. Exercisable voting rights stood at 635,332,063. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Getlink SE published the original content used to generate this news brief via Business Wire (Ref. ID: 202610051200BIZWIRE_USPR_____20261005_BW048564) on October 05, 2026, and is solely responsible for the information contained therein.
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
11:12 AM EDT, 10/05/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.14% to 1,883.96 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by lender Banco Santander (SAN) and brewing company Anheuser-Busch InBev (BUD), which advanced 3.2% and 0.8% respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which were up 0.6% and 0.3% respectively. The decliners from continental Europe were led by biopharmaceutical company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which lost 3.2% each. They were followed by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which decreased 0.9% and 0.4%, respectively. The gainers from the UK were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and software firm Endava plc (DAVA), which climbed 17% and 1.6% respectively. They were followed by medical device maker Smith & Nephew (SNN) and biotech firm Trinity Biotech (TRIB), which increased 1.2% and 1.4% respectively. The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 3.9% and 1.4% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and pharmaceutical company GSK (GSK), which fell 1.1% and 1% respectively.
Bitcoin Returns Reliant on Major Days -- Market Talk
1105 ET - Bitcoin's strong year-over-year returns are more linked to single days of strong moves, according to Zach Pandl of Grayscale in a note. Pandl says removing bitcoin's five best trading days reduces its three-year return from 225% to 95%, with the return falling to 27% without its 10 best days. If you remove the top fifteen days, it turns a three-year gain into an 11% loss. By comparison, removing the Nasdaq's fifteen best days reduces its cumulative return from 109% to 21%. "Given BTC's return and volatility profile, investors looking for long-term capital appreciation can avoid trying to time the market and instead seek consistent, long-term exposure to the asset," Pandl says. Bitcoin is down 0.2% to $85,610, while ethereum falls 0.2% to $2,701. (kirk.maltais@wsj.com) (END) Dow Jones Newswires October 05, 2026 11:05 ET (15:05 GMT)
Crypto prices
More
